Hypothesis

We propose that the TNF secreted by age‑associated B cells (ABCs) does more than suppress lymphopoiesis; it directly dampens AID expression in germinal‑center B cells through an epigenetic mechanism involving p38 MAPK‑dependent histone deacetylation at the Aicda promoter. This creates a feed‑forward loop that reduces somatic hypermutation (SHM) and impairs affinity‑based selection, thereby accelerating repertoire contraction in aging.

Predictions

1. In aged mice, ABC‑derived TNF levels will correlate inversely with Aicda mRNA and protein abundance in GC B cells.
2. Neutralizing TNF (with anti‑TNF antibody or genetic TNF knockout) in aged mice will restore AID expression, increase SHM rates (especially replacement mutations in CDRs), and broaden the peripheral B‑cell repertoire without altering bone‑marrow output.
3. Pharmacologic inhibition of p38 MAPK in aged B cells will mimic the effect of TNF blockade on AID expression.
4. Chromatin immunoprecipitation will show increased HDAC1 occupancy and reduced acetyl‑H3K27 at the Aicda promoter in GC B cells from aged mice; this signature will be lost after TNF neutralization.

Experimental Approach

• Mouse models: Use C57BL/6 mice aged 20‑24 months. Treat cohorts with anti‑TNFα antibody (infliximab‑equivalent) or isotype control for 4 weeks. Include a group of TNF‑deficient (Tnf‑/-) aged mice as genetic control.
• Readouts: Flow cytometry to quantify ABCs (CD11c+Tbet+ B cells) and GC B cells (GL7+Fas+). Intracellular staining for AID. Quantify serum IgG affinity to NP‑OVA using ELISA with varying hapten concentrations. High‑throughput IgV sequencing to compute SHM frequency, replacement/silent ratio in CDRs Vκ4 and VH6, and clonal diversity indices (Shannon, inverse Simpson).
• Mechanistic assays: Isolate GC B cells for Western blot of phospho‑p38, HDAC1 acetylation status. Perform ChIP‑qPCR for acetyl‑H3K27 and HDAC1 at the Aicda promoter. Use ATAC‑seq to assess chromatin accessibility.
• In vitro validation: Culture sorted naive B cells from aged mice with recombinant TNF ± p38 inhibitor (SB203580) and measure Aicda transcription after CD40L+IL‑4 stimulation.

Potential Outcomes

• If TNF neutralization restores AID levels and SHM, the hypothesis is supported, indicating that ABC‑derived TNF is a key extrinsic driver of the intrinsic SHM defect observed in aging.
• If SHM remains low despite normalized AID, then additional blocks (e.g., impaired DNA‑repair or selection signals) dominate, prompting revision of the model.
• If p38 inhibition mimics TNF blockade, it positions the p38‑HDAC axis as the mechanistic link.

This framework is directly testable, falsifiable, and integrates the observed decline in bone‑marrow output, ABC accumulation, and SHM deficiency into a unified mechanism that could be therapeutically targeted to improve vaccine responses in the elderly.